t(9;22)(q34;q11) translocation is presumably the necessary and sufficient condition to provoke clinical manifestation of CML, what may be explained by the wide spectrum of biological functions of the resulting BCR-ABL1 fusion gene (163, 164). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.